THAT — Thalia Therapeutics Share News
0.000.00%
- £11.10m
- £9.59m
- £0.01m
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
TR-1: Standard form notification of major holdings
Posting of Circular and Notice of General Meeting
Placing and Subscription to raise £1,750,000
Holding(s) in Company
Investor Webinar
Investor Webinar
N4 Pharma Non-Executive Director Q&A
Directorate Changes
Brief: N4 Pharma Filed New Patent For Its IBD Product In Early Pre-Clinical Development
New Patent Filing
Grant of Options
N4 Pharma CEO Q&A Now LIVE
New Corporate Presentation
Brief: N4 Pharma H1 Basic EPS GBP -0.002
Interim Results
SRI Research Update